title: Hepatitis C treatment and quality of life - You can't always get what you want, but you might get what you need.
authors.affiliation: UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Campus, London NW3 2PF, United Kingdom.
authors.forename: Gautam
authors.initials: G
authors.lastname: Mehta
authors.affiliation: UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Campus, London NW3 2PF, United Kingdom. Electronic address: g.dusheiko@ucl.ac.uk.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Dusheiko
mesh_terms: D001562:Benzimidazoles / Q000008:administration & dosage*; D004279:DNA, Viral / Q000235:genetics*; D005260:Female; D005449:Fluorenes / Q000008:administration & dosage*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology*; D008297:Male; D011788:Quality of Life; D000069474:Sofosbuvir / Q000008:administration & dosage*
chemical_list: D001562:Benzimidazoles; D004279:DNA, Viral; D005449:Fluorenes; D000069474:Sofosbuvir
keywords: Antiviral therapy; Hepatitis C; Ledipasvir; Quality of life; Ribavirin; Sofosbuvir